1. Home
  2. LXFR vs ASMB Comparison

LXFR vs ASMB Comparison

Compare LXFR & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

HOLD

Current Price

$17.10

Market Cap

460.7M

Sector

Industrials

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$26.55

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXFR
ASMB
Founded
1898
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
460.7M
512.1M
IPO Year
2002
2010

Fundamental Metrics

Financial Performance
Metric
LXFR
ASMB
Price
$17.10
$26.55
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$44.20
AVG Volume (30 Days)
389.2K
133.4K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
3.65%
N/A
EPS Growth
N/A
91.78
EPS
0.13
N/A
Revenue
$384,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.01
$638.39
P/E Ratio
$131.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.26
$20.23
52 Week High
$19.45
$39.71

Technical Indicators

Market Signals
Indicator
LXFR
ASMB
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
LXFR
ASMB

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is engaged in materials engineering and the manufacture of materials, components, and gas containment products. The company has two reportable segments: Elektron and Gas Cylinders. The Elektron segment produces specialty materials based on magnesium and zirconium for applications in aerospace, defense, automotive, and industrial markets. The Gas Cylinders segment manufactures high-pressure gas containment products using aluminum alloys and carbon composite technologies for use in healthcare, emergency response, aerospace, and alternative fuel transportation markets.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: